Notification
No new Notification messages
Pranik Logistics IPO is Open!
Apply for the Pranik Logistics IPO through UPI in just minutes.
Latest: Network18 Q2 Results FY'25
Network18 group the parent brand of JioCinema and Moneycontrol announced its Q2 results for FY'25.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
gujarat themis biosyn ltd. stock

GUJARAT THEMIS BIOSYN LTD. Share Price

342 -6.14 (-1.76%)
Oct 11 2024 03:29 PM Pharmaceuticals NSE: GUJTHEM

GUJARAT THEMIS BIOSYN LTD. Share Price Update

As of the latest trading session, GUJARAT THEMIS BIOSYN LTD. share price is currently at 342, which is down by -6.14 from its previous closing. Today, the stock has fluctuated between 337.60 and 346.45. Over the past year, GUJARAT THEMIS BIOSYN LTD. has achieved a return of 132.62 %. In the last month alone, the return has been -0.58 %. Read More...

GUJARAT THEMIS BIOSYN LTD. Performance

Day Range

Low337.60 High346.45
341.65

52 Week Range

Low 108.25 High 390.00
341.65

GUJARAT THEMIS BIOSYN LTD. Share Price

506879

GUJTHEM

img img img img
No Data Available

Open Price

345.00

Prev. Close

348.15

Volume (Shares)

14817.00

Total traded value

50.56

Upper Circuit

409.95

Lower Circuit

273.35

Note: The current prices & values are delayed, Login to your account for live updates.

GUJARAT THEMIS BIOSYN LTD. Fundamentals


(Standalone)

Market Cap (Cr) 3722.80
PE Ratio (TTM) 68.06
Book Value / Share 18.48
Beta 1.15
ROE 33.76%
EPS (TTM) 5.02
Dividend Yield 0.20%
Net Profit Qtr (Cr) 13.24

GUJARAT THEMIS BIOSYN LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 38.83
Operating Expense 21.50
Net Profit 13.24
Net Profit Margin (%) 34.09
Earnings Per Share (EPS) 1.82
EBITDA 19.08
Effective Tax Rate (%) 25.86
Particulars MAR 2024 (Values in Cr)
Revenue 42.01
Operating Expense 22.08
Net Profit 15.89
Net Profit Margin (%) 37.82
Earnings Per Share (EPS) 2.19
EBITDA 21.94
Effective Tax Rate (%) 24.15
Particulars DEC 2023 (Values in Cr)
Revenue 38.57
Operating Expense 22.15
Net Profit 13.01
Net Profit Margin (%) 33.73
Earnings Per Share (EPS) 1.79
EBITDA 18.75
Effective Tax Rate (%) 26.45
Particulars SEP 2023 (Values in Cr)
Revenue 39.65
Operating Expense 23.77
Net Profit 12.54
Net Profit Margin (%) 31.62
Earnings Per Share (EPS) 8.63
EBITDA 17.82
Effective Tax Rate (%) 25.69
Particulars JUN 2023 (Values in Cr)
Revenue 49.59
Operating Expense 26.86
Net Profit 17.72
Net Profit Margin (%) 35.73
Earnings Per Share (EPS) 12.20
EBITDA 24.59
Effective Tax Rate (%) 25.57
Particulars MAR 2024 (Values in Cr)
Revenue 169.82
Operating Expense 94.85
Net Profit 59.16
Net Profit Margin (%) 34.83
Earnings Per Share (EPS) 8.14
EBITDA 83.10
Effective Tax Rate (%) 25.42
Particulars MAR 2023 (Values in Cr)
Revenue 148.39
Operating Expense 77.51
Net Profit 57.97
Net Profit Margin (%) 39.06
Earnings Per Share (EPS) 39.90
EBITDA 80.22
Effective Tax Rate (%) 25.17
Particulars MAR 2022 (Values in Cr)
Revenue 114.85
Operating Expense 59.87
Net Profit 43.62
Net Profit Margin (%) 37.97
Earnings Per Share (EPS) 30.03
EBITDA 62.08
Effective Tax Rate (%) 26.10
Particulars MAR 2021 (Values in Cr)
Revenue 90.56
Operating Expense 52.94
Net Profit 30.18
Net Profit Margin (%) 33.32
Earnings Per Share (EPS) 20.77
EBITDA 43.58
Effective Tax Rate (%) 26.17
Particulars MAR 2020 (Values in Cr)
Revenue 85.12
Operating Expense 55.57
Net Profit 23.67
Net Profit Margin (%) 27.80
Earnings Per Share (EPS) 16.30
EBITDA 33.54
Effective Tax Rate (%) 24.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 138.60
ROE % 33.76
ROCE % 44.82
Total Debt to Total Equity 0.01
EBITDA Margin 48.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 102.66
ROE % 45.92
ROCE % 60.85
Total Debt to Total Equity 0.01
EBITDA Margin 54.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 71.11
ROE % 50.35
ROCE % 66.38
Total Debt to Total Equity 0.03
EBITDA Margin 54.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.14
ROE % 53.83
ROCE % 66.39
Total Debt to Total Equity 0.12
EBITDA Margin 48.13
Particulars MAR 2020 (Values in Cr)
Book Value / Share 29.04
ROE % 77.98
ROCE % 84.80
Total Debt to Total Equity 0.23
EBITDA Margin 39.40
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.15
Total Assets 221.11
Total Liabilities 221.11
Total Equity 201.37
Share Outstanding 14528702
Price to Book Ratio 2.86
Return on Assets (%) 26.75
Return on Capital (%) 29.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.33
Total Assets 166.32
Total Liabilities 166.32
Total Equity 149.14
Share Outstanding 14528702
Price to Book Ratio 6.69
Return on Assets (%) 34.85
Return on Capital (%) 38.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.34
Total Assets 122.50
Total Liabilities 122.50
Total Equity 103.32
Share Outstanding 14528702
Price to Book Ratio 5.73
Return on Assets (%) 35.61
Return on Capital (%) 42.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 27.63
Total Assets 88.26
Total Liabilities 88.26
Total Equity 69.94
Share Outstanding 14528702
Price to Book Ratio 4.23
Return on Assets (%) 34.19
Return on Capital (%) 41.36
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.08
Total Assets 64.07
Total Liabilities 64.07
Total Equity 42.19
Share Outstanding 14527902
Price to Book Ratio 3.35
Return on Assets (%) 36.94
Return on Capital (%) 52.17
Particulars MAR 2024 (Values in Cr)
Net Income 79.33
Cash from Operations 83.99
Cash from Investing -55.21
Cash from Financing -8.58
Net change in Cash 0.41
Free Cash Flow 158.63
Particulars MAR 2023 (Values in Cr)
Net Income 77.46
Cash from Operations 59.89
Cash from Investing -20.40
Cash from Financing -13.27
Net change in Cash 5.79
Free Cash Flow 83.60
Particulars MAR 2022 (Values in Cr)
Net Income 59.03
Cash from Operations 54.82
Cash from Investing -29.83
Cash from Financing -13.99
Net change in Cash -3.51
Free Cash Flow 68.72
Particulars MAR 2021 (Values in Cr)
Net Income 40.88
Cash from Operations 20.65
Cash from Investing -2.25
Cash from Financing -5.16
Net change in Cash 3.11
Free Cash Flow 23.71
Particulars MAR 2020 (Values in Cr)
Net Income 31.25
Cash from Operations 7.60
Cash from Investing -2.98
Cash from Financing 2.09
Net change in Cash -0.25
Free Cash Flow 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 60.41 39.23 3.37 462.94 35.27 / 77.70
BLISS GVS PHARMA LTD 127.90 13.17 1.39 1346.81 77.65 / 148.95
CIPLA LTD 1595.25 28.98 4.82 128827.12 1132.00 / 1702.00
FERMENTA BIOTECH LIMITED 313.60 0.00 3.19 922.96 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2782.55 61.20 26.51 47138.08 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 60.41 91.53 11.48 462.94 35.27 / 77.70
AMRUTAJAN HEALTH LTD 773.90 52.54 7.75 2237.39 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 7788.20 148.63 27.34 19470.50 4050.15 / 8139.85
BLISS GVS PHARMA LTD 127.90 13.80 1.36 1346.81 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 341.70
  • 26 Days 351.70
  • 10 Days 349.20
  • 50 Days 349.80
  • 12 Days 351.60
  • 100 Days 331.90
  • 20 Days 352.10
  • 200 Days 158.80
344.88
PIVOT
First Resistance 353.27
Second Resistance 358.38
Third Resistance 366.77
First Support 339.77
Second Support 331.38
Third Support 326.27
RSI 51.73
MACD 0.79
Commodity Channel Index (CCI) -58.89
ADX 25.69
Williams % R -59.40

Over 1 Month

down

-0.58

Over 3 Months

down

4.25

Over 6 Months

down

33.12

Over 1 Year

down

132.62

Over 3 Years

down

64.15

Over 5 Years

down

120.32

GUJARAT THEMIS BIOSYN LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GUJARAT THEMIS BIOSYN LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.52
Promoter Holdings
70.86
FII
1.43
DII
1.17
Promoter Shares(Pledge Percentage)
3.3
Name Category Shares Shares%
Pharmaceutical Business Group (india) Ltd Shareholding of Promoter and Promoter Group 3.416E7 47.02
Themis Medicare Limited Shareholding of Promoter and Promoter Group 1.6848025E7 23.19
Quant Mutual Fund - Quant Manufacturing Fund Public Shareholding 836000.0 1.15
Dipak Kanayalal Shah Public Shareholding 740000.0 1.02
Jayshree D Patel Shareholding of Promoter and Promoter Group 353225.0 0.49
Sachin Dinesh Patel Shareholding of Promoter and Promoter Group 35500.0 0.05
Reena S Patel Shareholding of Promoter and Promoter Group 28000.0 0.04
Dinesh Shantilal Patel Shareholding of Promoter and Promoter Group 23505.0 0.03
Nysha Rupen Choksi Shareholding of Promoter and Promoter Group 15235.0 0.02
Anay Rupen Choksi Shareholding of Promoter and Promoter Group 15235.0 0.02

GUJARAT THEMIS BIOSYN LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-22 0.75 Interim 2024-02-22 Equity shares 2023-09-01 1.0 Final 2023-09-02 Equity shares 2022-12-01 4.4 Interim 2022-12-02 Equity shares 2022-08-29 4.0 Final 2022-08-31 Equity shares 2021-11-24 2.0 Interim 2021-11-25 Equity shares 2021-11-24 5.0 Special 2021-11-25 Equity shares 2020-09-10 1.65 Final 2020-09-14 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2023-10-10 5.0 1.0 2023-10-10

Learn More About Stocks

About GUJARAT THEMIS BIOSYN LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GUJARAT THEMIS BIOSYN LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Gujarat Themis Biosyn Ltd?

Answer Field

The share price of Gujarat Themis Biosyn Ltd for NSE is ₹ 7.30 and for BSE is ₹ 341.65.

What is the Market Cap of Gujarat Themis Biosyn Ltd?

Answer Field

The market cap of Gujarat Themis Biosyn Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 37,22.80 Cr. as of now.

What is the 52 Week High and Low of Gujarat Themis Biosyn Ltd?

Answer Field

The 52 Week High and Low of Gujarat Themis Biosyn Ltd for NSE is ₹ 7.50 and ₹ 0.00 and for BSE is ₹ 390.00 and ₹ 108.20.

How to Buy Gujarat Themis Biosyn Ltd share?

Answer Field

You can trade in Gujarat Themis Biosyn Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gujarat Themis Biosyn Ltd?

Answer Field

The 1 year returns on the stock has been 132.62%.

What is the Current Share Price of Gujarat Themis Biosyn Ltd?

Answer Field

Gujarat Themis Biosyn Ltd share price is for NSE ₹ 7.30 & for BSE ₹ 341.65 as on Oct 11 2024 03:29 PM.

What is the Market Cap of Gujarat Themis Biosyn Ltd Share?

Answer Field

The market cap of Gujarat Themis Biosyn Ltd for NSE ₹ 0.0 & for BSE ₹ 37,22.80 as on Oct 11 2024 03:29 PM.

What is the P/E Ratio of Gujarat Themis Biosyn Ltd Share?

Answer Field

As on Oct 11 2024 03:29 PM the price-to-earnings (PE) ratio for Gujarat Themis Biosyn Ltd share is 68.06.

What is the PB ratio of Gujarat Themis Biosyn Ltd Share?

Answer Field

As on Oct 11 2024 03:29 PM, the price-to-book (PB) ratio for Gujarat Themis Biosyn Ltd share is 18.48.

How to Buy Gujarat Themis Biosyn Ltd Share?

Answer Field

You can trade in Gujarat Themis Biosyn Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Themis Biosyn Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Themis Biosyn Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Themis Biosyn Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader